secwatch.observer — SEC 8-K summary
======================================

Issuer:     FENNEC PHARMACEUTICALS INC. (FENC)
CIK:        0001211583
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001104659-25-113915
Event type: debt
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fennec Pharmaceuticals redeems all convertible notes, now debt-free
-------------------------------------------------------------------

- Redeemed all remaining Petrichor convertible notes for $21.73M (principal $19.48M, accrued interest $305k, redemption fee $1.95M).
- Used proceeds from underwritten public offering and private placement closed Nov 17-18, 2025.
- Company has no outstanding debt after the redemption.
- Notes previously bore interest at prime rate plus 4.5% (floor 3.5%) and had maturity Aug 19, 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925113915/0001104659-25-113915-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1211583/000110465925113915/tm2531627d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-113915

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer